Navigation Links
For one Stanford doctor, the beat goes on during open-heart surgery

y used in about 22 percent of U.S. bypass procedures - a surgeon's ability to stitch vessels onto a moving, blood-filled heart replaces the need for the heart-lung machine. A stabilizer, a small device with a suction cup attached, is used to minimize the motion of the heart where the stitching is done.

The hesitancy of most surgeons to switch to beating-heart surgery is, in part, due to the overall success of the heart-lung machine over the past 40 years. In other words, if it ain't broke, why fix it?

But proponents of beating-heart surgery, such as Ihnken, point to the risks associated with conventional bypass surgery, including blood loss, stroke and kidney failure. Because the body doesn't have the added stress of being put on a heart-lung machine, beating-heart surgery can reduce these risks, and does so particularly well among such high-risk groups as the elderly and, surprisingly, women, Ihnken said.

"For reasons not well-understood, women don't do as well during bypass as men," Ihnken said. "Women have double the mortality rates following bypass."

Besides his own positive experiences with the technique, Ihnken points to a recent report in the new journal Innovations, which presents an analysis by an international group of doctors of more than 150 previous studies of the procedure. It found that the beating-heart technique is as safe as conventional heart surgery, with fewer complications and lower costs. The consensus report, based on randomized controlled trials and retrospective studies, concluded that when complications such as blood loss, stroke, kidney failure and irregular heart beats were considered, beating-heart surgery had a definite advantage over conventional bypass.

"Beating-heart surgery is an advance in cardiac surgery because it provides a better result for patients," said John Puskas, chief of cardiothoracic surgery at Emory Crawford Long Hospital, Atlanta, and one of the 12 authors of the paper.


'"/>

Source:Stanford University Medical Center


Page: 1 2 3

Related biology news :

1. Same mutation aided evolution in many fish species, Stanford study finds
2. First real-time view of developing neurons reveals surprises, say Stanford researchers
3. Stem cells from brain transformed to produce insulin at Stanford
4. Stanford gut check shows diversity of intestinal ecosystem
5. Young Blood Revives Aging Muscles, Stanford Researchers Find
6. Stem cell training program to make its Stanford debut
7. Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds
8. Sooner is better with cochlear implants, Stanford scientist shows
9. Learning to love bacteria: Stanford scientist highlights bugs benefits
10. Stanford study of owls finds link in brain between sight and sound
11. Stanford/Packard scientists data-mining technique strikes genetic gold

Post Your Comments:
(Date:12/2/2009)... are reporting the first identification of substan... that changes harmless marine bacteria into killer...s in ACS, Environmental Science & Technology , a ...es note that bleaching already has destroyed up to...ists are searching for ways to slow or stop the da...
(Date:12/2/2009)...led nanotubescylinders of carbon about a nanometer...applications such as ultrastrong fibers, electrica...components for fuel cells. Thanks to a new develop...tandards and Technology (NIST) and five partners, ...ction and destruction of an aggressive form of bre...
(Date:12/2/2009)...009) HOBOKEN, NJ According to the National Insti...ans diagnosed with diabetes already have some stag...damage to the retina caused by leaky blood vessels...betes and is one of the most feared diabetic compl...ts who,ve had diabetes for 10 years or more will e...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3Cervical Cancer Vaccine Not Just for Teens 47617 1Cervical Cancer Vaccine Not Just for Teens 47617 2I SPY trial offers key insights into locally advanced breast cancer 47614 1I SPY trial offers key insights into locally advanced breast cancer 47614 2I SPY trial offers key insights into locally advanced breast cancer 47614 3More stringent evaluation on the use of generic medications in thoracic transplantation 47611 1More stringent evaluation on the use of generic medications in thoracic transplantation 47611 2
...ers at CSIRO Livestock Industries, Australian Anim...epartment of Primary Industries Victoria ?are inve...g the introduced fish. , Project leader Dr Mark C... in 1998*, caused mass mortalities in carp in the ...onesia. So far the virus does not appear to have r...
...ed immune response resulting from HIV infection ca...a, according to a new study appearing in the Oct. ... available online. , "Our study demonstrates that ...epresent, next to children and pregnant women, an ...n-Pierre Van geertruyden, MD, MSc, lead author of ...
...as 18 percent of adults who have no history of str...ke, according to results of a large national study...nternal Medicine, one of the JAMA/Archives journal...hout a history of stroke reveals that many have ha...ckground information in the article. One previous...
Other Biology News:Virus may control Australia's 2Malaria treatment efficacy compromised in certain HIV-positive patients 2Stroke symptoms common among general population 2
(Date:12/1/2009)... , SARASOTA, Fla., Dec. 1 Exp...Osprey Biotechnics Inc. of Sarasota has appointed ...butor. ,, Lake is located near Birmingham, Eng... bacteria which serve the agricultural, waste wate...d to be hungry and to open drain fields, and clean...
(Date:12/1/2009)... EpiVax, Inc. today announced a... RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax...ould potentially reduce detrimental immune respons...iVax collaboration, the EpiVax Tregitope technolog...enicity of protein therapeutics. , ...
(Date:12/1/2009)... , HUNTINGTON BEACH, California and AM...ld leader in molecular cancer diagnostics, announc...dicare administrator, has established,coding guide...t is Agendia,s,FDA-cleared breast cancer recurrenc...2008. , Patients across the United States...
(Date:12/1/2009)..., NEW YORK and MONTREAL, Dec. 1 /PRNewswire-Fir...er -ICBS Ltd. (OTCPK: ICBT), announced today that ...anufacturing Inc., of Canada for the manufacturing...ribution in the U.S. ,, "We have seen the disas...resh vegetables and packaged salads in the past" s...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...SULTS, VANCOUVER, Oct. 25 /PRNewswire-FirstCall/ ...TSX: ANP), a global specialty pharmaceutical and,m... discussing its,financial results for the third qu...ember 1, 2007 at 11:00 AM ET, (8:00 AM Pacifi...information is as follows:, North America (to...
...AACR-NCI-EORTC International Conference on M...ancisco, QUEBEC CITY, Oct. 25 /PRNewswire-FirstCa...S), a global biopharmaceutical company focused on,... abstract outlining novel,data generated from thre...eted cytotoxic candidates at the AACR-NCI-EORTC In...
... Therapeutics,Inc. (OTC Bulletin Board: NILT.OB) w...lthcare Conference at 10:30 AM EST on Wednesday, N...Peter Strumph, Chief Executive Officer of Nile wil... clinical development programs,including data from...ead,compound, CD-NP, a novel chimeric peptide for ...
Other Biology Technology:Notice of Conference Call and Webcast 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 3AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 4Nile Therapeutics to Present at the Rodman & Renshaw 9th Annual Healthcare Conference 2
...6820 GC system combines world-class performance ha...QA/QC software, Agilents world-renowned support an...and supplies--a combination that lets you reach un...sions based on dependable data. The Agilent 6820 G...
...PolarScreen Peroxisome Proliferator-Activated Rece...de a sensitive and efficient method for studying a...orescence polarization (FP). The kit contains huma...with an N-terminal His-tag and a novel, selective ...
...MSQ™ Plus is a small and sensitive single q...d IC. It features a newly designed self-cleaning t...API) source for outstanding sensitivity and noise ...g LC and IC methods, especially those including sa...
RF-5301 Fluorescence Spectrophotometer from Shimadzu
Biology Products: